Cargando…
Adverse transverse-tubule remodeling in a rat model of heart failure is attenuated with low-dose triiodothyronine treatment
ABSTRACT: Pre-clinical animal studies have shown that triiodothyronine (T3) replacement therapy improves cardiac contractile function after myocardial infarction (MI). We hypothesized that T3 treatment could prevent adverse post-infarction cardiomyocyte remodeling by maintaining transverse-tubule (T...
Autores principales: | An, Shimin, Gilani, Nimra, Huang, Yuan, Muncan, Adam, Zhang, Youhua, Tang, Yi-Da, Gerdes, A. Martin, Ojamaa, Kaie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898920/ https://www.ncbi.nlm.nih.gov/pubmed/31810440 http://dx.doi.org/10.1186/s10020-019-0120-3 |
Ejemplares similares
-
BNP as a New Biomarker of Cardiac Thyroid Hormone Function
por: Wang, Kaihao, et al.
Publicado: (2020) -
Chronic dantrolene treatment attenuates cardiac dysfunction and reduces atrial fibrillation inducibility in a rat myocardial infarction heart failure model
por: Nofi, Colleen, et al.
Publicado: (2020) -
Safe Oral Triiodo-L-Thyronine Therapy Protects from Post-Infarct Cardiac Dysfunction and Arrhythmias without Cardiovascular Adverse Effects
por: Rajagopalan, Viswanathan, et al.
Publicado: (2016) -
Eps 15 Homology Domain (EHD)-1 Remodels Transverse Tubules in Skeletal Muscle
por: Demonbreun, Alexis R., et al.
Publicado: (2015) -
Remuscularization with triiodothyronine and β(1)-blocker therapy reverses post-ischemic left ventricular dysfunction and adverse remodeling
por: Bogush, Nikolay, et al.
Publicado: (2022)